Subscribe
ca-ssis
ca-ssis / iStockphoto.com
31 January 2019Americas

FDA approved record number of novel devices in 2018

A record number of novel devices were approved by the  US Food and Drug Administration (FDA) in 2018, the federal agency has said.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.
Americas
FDA announces new measures to boost gene therapy innovation
16 January 2019   The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.
Americas
FDA announces new measures to boost gene therapy innovation
16 January 2019   The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.

More on this story

Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.
Americas
FDA announces new measures to boost gene therapy innovation
16 January 2019   The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?